EVOX THERAPEUTICS LIMITED

• 72110 - Research and experimental development on biotechnology

Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on improving the natural delivery capabilities of exosomes, and developing an entirely new class of therapeutics... Evox has developed an unparalleled proprietary technology platform, DeliverEX®, to enable it to modify exosomes, to load drugs into exosomes, and to target the delivery of these exosomes to organs of interest. Evox has successfully demonstrated this capability by delivering drug-loaded exosomes into target organs including the central nervous system and other intractable tissues. Exosome-based drugs have the potential to address some of the limitations of protein, antibody, and nucleic acid-based therapies by enabling delivery to cells and tissues that are currently out of reach using other drug delivery technologies. Evox is leading the development within this emerging space and the company is poised to break new ground in the treatment of severe rare genetic disorders using its innovative..

Also known as: Evox, Evox Therapeutics

Registration numbers: 10076821 (CH)

VAT numbers: GB 247 0490 10

Primary location: Oxford United Kingdom